Canada· CA-DIN-00645575

PHENOBARB ELIXIR

A phenobarbital product containing phenobarbital, registered in Canada by PENDOPHARM DIVISION OF PHARMASCIENCE INC. The same ATC class is registered in 15 of our 19 countries.

ATC N03AA02

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about phenobarbitalAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Phenobarbital is registered in 15 of 19 countries.

Countries holding a registration under ATC N03AA02 (phenobarbital), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
8 of them publish a price we can compare per daily dose

Search phenobarbital products by name

Phenobarbital · ATC N03AA02

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of phenobarbital costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Phenobarbital · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

IT Italy$0.10

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: PHENOBARBITAL
Manufacturer: PENDOPHARM DIVISION OF PHARMASCIENCE INC
Country: Canada (CA)
ATC code: N03AA02
ATC class: Phenobarbital
Defined daily dose: 0.1 g, O
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

433 interactions on record for phenobarbital.

Graded by severity as the source publishes them — 133 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check phenobarbital against other medicines How interaction checks work

Phenobarbital · interactions on record

433 records

133 severe
236 moderate
19 minor

Most severe, free to view

RolapitantA04AD14severe
NaloxegolA06AH03severe
NaldemedineA06AH05severe
EliglustatA16AX10severe

45 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Phenobarbital in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phenobarbital products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

Belgium · Gardenal, Phenobarbital Sodium Sterop
Bulgaria · Фенобарбитал Софарма
Czechia · Luminal, Phenaemal
Germany · Luminal, Luminaletten
Denmark · Fenemal
Estonia · Phenaemal
Spain · Luminal, Luminaletas
France · Gardenal
United Kingdom (Northern Ireland) · Phenobarbital Accord, Phenobarbital Activase
Greece · Gardenal
Croatia · Phenobarbiton
Hungary · Sevenal, Sevenaletta
Ireland · Phenobarbital Clonmel Healthcare
Italy · Fenobarbitale Sodico S.A.L.F, Gardenale
Luxembourg · Gardenal
Netherlands · Fenobarbital Teva
Norway · Fenemal
Poland · Luminalum, Luminalum Unia
Portugal · Bialminal, Fenobarbital Labesfal
Romania · Fenobarbital Arena, Fenobarbital Zentiva
Slovakia · Luminal, Phenaemal 0,1

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d384e073-9027-497d-9715-43a2a25f012d
GET /v1/drugs/d384e073-9027-497d-9715-43a2a25f012d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "00645575",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "N03AA02",
  "schedule": [
    "Schedule G (CDSA IV)"
  ],
  "drug_code": "6095",
  "strengths": [
    "5 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "PHENOBARBITAL"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about phenobarbital.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console